MedTrace Logo

Re-link HCV in Substance-Use Telemedicine Program

NCT06349902 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2024-04-05

No results posted yet for this study

Summary

This is an observational, retrospective \& prospective cohort study. The retrospective element of the study is a chart review to identify people with diagnosed but untreated HCV and re-link them to care. The observational prospective cohort element of the study will examine the HCV linkage to care, treatment initiation, treatment completion \& cure rates of these HCV clients achieved through this chart review and re-linking approach.

Conditions

  • Hepatitis C

Interventions

BEHAVIORAL

Re-Link

The HCV nurse will attempt to contact the PWDU HCV via phone call and text. If unable to connect with a client via phone, an alert is added to the client's chart in the electronic medical record. When the client presents to the CBSUTP for their regular substance use follow up appointment, the chart alert is flagged by the administrative team and the client is connected with the HCV nurse via telemedicine. Clients who are connected to the HCV team are considered re-linked. The HCV nurse will provide an HCV intake as per program guidelines. Clients who would prefer to pursue treatment elsewhere will be supported with a referral to their family doctor or an alternative HCV program in the community. Clients who choose to be treated at the CBSUTP will receive a HCV consultation, DAA treatment and follow-up from the HCV clinical team onsite as per existing program guidelines.

Sponsors & Collaborators

  • Gilead Sciences

    collaborator INDUSTRY

  • trueNorth Medical Centres

    lead OTHER

Principal Investigators

  • Hannah O'Reilly · trueNorth Medical

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-12
Primary Completion
2024-08-31
Completion
2024-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06349902 on ClinicalTrials.gov